Works matching IS 03407004 AND DT 2024 AND VI 73 AND IP 7

Results: 20

The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03712-7

By:

Yin, Xiaoyan;
Liu, Xinchao;
Ren, Fei;
Meng, Xiangjiao

Publication type:

Article

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03711-8

By:

Shimazu, Yutaka;
Kanda, Junya;
Onda, Yoshiyuki;
Fuchida, Shin-ichi;
Ohta, Kensuke;
Shimura, Yuji;
Kosugi, Satoru;
Yamamura, Ryosuke;
Matsuda, Mitsuhiro;
Hanamoto, Hitoshi;
Adachi, Yoko;
Anzai, Naoyuki;
Hotta, Masaaki;
Fukushima, Kentaro;
Yagi, Hideo;
Yoshihara, Satoshi;
Tanaka, Yasuhiro;
Takakuwa, Teruhito;
Tanaka, Hirokazu;
Shibayama, Hirohiko

Publication type:

Article

The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03726-1

By:

Li, Ji-Bin;
Lai, Ming-Yu;
Lin, Zhuo-Chen;
Guan, Wen-Long;
Sun, Yu-Ting;
Yang, Jing;
Wang, Wen-Xuan;
Yang, Zhi-Rong;
Qiu, Miao-Zhen

Publication type:

Article

Effect of radiochemotherapy on peripheral immune response in glioblastoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03722-5

By:

Hampe, Léa;
Daumoine, Susy;
Limagne, Emeric;
Roussot, Nicolas;
Borsotti, François;
Vincent, Julie;
Ilie, Sylvia;
Truntzer, Caroline;
Ghiringhelli, François;
Thibaudin, Marion

Publication type:

Article

GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03716-3

By:

Zhao, Wenjing;
Liang, Ziwei;
Yao, Yongshi;
Ge, Yang;
An, Guangyu;
Duan, Ling;
Yao, Jiannan

Publication type:

Article

circATAD2 mitigates CD8<sup>+</sup> T cells antitumor immune surveillance in breast cancer via IGF2BP3/m<sup>6</sup>A/PD-L1 manner.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03705-6

By:

Zhang, Zhiling;
Huo, Wenjie;
Li, Jie

Publication type:

Article

Codonopsis pilosula-derived glycopeptide dCP1 promotes the polarization of tumor-associated macrophage from M2-like to M1 phenotype.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03694-6

By:

Liu, Hongxu;
Yao, Maojin;
Ren, Jiaoyan

Publication type:

Article

Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03670-0

By:

Lian, Fenbao;
Yang, Haitao;
Hong, Rujun;
Xu, Hang;
Yu, Tingting;
Sun, Gang;
Zheng, Guanying;
Xie, Baosong

Publication type:

Article

Epigenetic silencing of LDHB promotes hepatocellular carcinoma by remodeling the tumor microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03717-2

By:

Zhang, Peng;
Wan, Yi;
Ma, Jinrong;
Gong, Jin;
Zhong, Ziwei;
Cui, Yuxin;
Zhang, Hongli;
Da, Yanyan;
Ma, Junpeng;
Li, Chenxi;
Liu, Lijuan;
Gong, Tian;
Tan, Youwen;
Zhang, Chengsheng

Publication type:

Article

Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03715-4

By:

Ren, Shengxiang;
Xiong, Anwen;
Yu, Jia;
Wang, Xicheng;
Han, Baohui;
Pan, Yueyin;
Zhao, Jun;
Cheng, Yufeng;
Hu, Sheng;
Liu, Tianshu;
Li, Yalun;
Cheng, Ying;
Feng, Jifeng;
Yi, Shanyong;
Gu, Shanzhi;
Gao, Shegan;
Luo, Yongzhong;
Liu, Ying;
Liu, Caigang;
Duan, Huijie

Publication type:

Article

Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03710-9

By:

Zhang, Chaoting;
Li, Shance;
Shen, Luyan;
Teng, Xia;
Xiao, Yefei;
Yang, Wenjun;
Lu, Zheming

Publication type:

Article

Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03707-4

By:

Ikoma, Tatsuki;
Matsumoto, Toshihiko;
Boku, Shogen;
Motoki, Yusuke;
Kinoshita, Hidefumi;
Kosaka, Hisashi;
Kaibori, Masaki;
Inoue, Kentaro;
Sekimoto, Mitsugu;
Fujisawa, Takuo;
Iwai, Hiroshi;
Naganuma, Makoto;
Tanizaki, Hideaki;
Hisamatsu, Yoji;
Okada, Hidetaka;
Kurata, Takayasu

Publication type:

Article

The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03698-2

By:

Jin, Ya-Nan;
Qiang, Meng-Yun;
Wang, Ying;
Lin, Yu-Jing;
Jiang, Ren-Wei;
Cao, Wan-Wei;
Zhang, Wang-Jian;
Wang, Si-Yang;
Zhang, Hong-Yu;
Yao, Ji-Jin

Publication type:

Article

Integrative analysis of single-cell and bulk RNA sequencing unveils a machine learning-based pan-cancer major histocompatibility complex-related signature for predicting immunotherapy efficacy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03714-5

By:

Feng, Jia-Lin;
Liang, Bo;
Zheng, Wen-Jie;
Xu, Le;
Zhou, Qin-Yi;
Chen, Jun

Publication type:

Article

Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03702-9

By:

Wu, Xin;
Mi, Tao;
Jin, Liming;
Ren, Chunnian;
Wang, Jinkui;
Zhang, Zhaoxia;
Liu, Jiayan;
Wang, Zhaoyin;
Guo, Peng;
He, Dawei

Publication type:

Article

Long-term survival after anti-PD-1 discontinuation in advanced cutaneous squamous cell carcinoma (cSCC): a proof of concept of benefit of concomitant cemiplimab and radiotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03700-x

By:

Bailly-Caillé, Barbara;
Levard, Romain;
Kottler, Diane;
Dompmartin, Anne;
L'Orphelin, Jean-Matthieu

Publication type:

Article

Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03699-1

By:

Liu, Yansong;
Li, Mingcui;
Fang, Zhengbo;
Gao, Shan;
Cheng, Weilun;
Duan, Yunqiang;
Wang, Xuelian;
Feng, Jianyuan;
Yu, Tianshui;
Zhang, Jiarui;
Wang, Ting;
Hu, Anbang;
Zhang, Hanyu;
Rong, Zhiyuan;
Shakila, Suborna S.;
Shang, Yuhang;
Kong, Fanjing;
Liu, Jiangwei;
Li, Yanling;
Ma, Fei

Publication type:

Article

Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03697-3

By:

Moser, Justin C.;
Bhatia, Shailender;
Amin, Asim;
Pavlick, Anna C.;
Betts, Keith A.;
Du, Ella Xiaoyan;
Poretta, Tayla;
Shelley, Karishma;
Srinivasan, Swetha;
Sakkal, Leon Alan;
Palaia, Jennell;
Lobo, Maurice;
Pe Benito, Melanie;
Linton, Joshua A.;
Chen, Yan;
Xu, Churong;
Yin, Lei;
Sundar, Manasvi;
Weber, Jeffrey

Publication type:

Article

Chemoradiotherapy versus surgery after neoadjuvant chemoimmunotherapy in patients with stage III NSCLC: a real-world multicenter retrospective study.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03696-4

By:

Guan, Song;
Sun, Jifeng;
Wang, Yuan;
Han, Sibei;
Chen, Chen;
Yue, Dongsheng;
Huang, Yubei;
Ren, Kai;
Wang, Jun;
Zhao, Lujun

Publication type:

Article

Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03677-7

By:

Zhang, Panpan;
Chen, Zhendong;
Shi, Si;
Li, Zhiping;
Ye, Feng;
Song, Lijie;
Zhang, Yanqiao;
Yin, Fei;
Zhang, Xing;
Xu, Jianming;
Cheng, Ying;
Su, Weiguo;
Shi, Michael;
Fan, Songhua;
Tan, Panfeng;
Zhong, Chen;
Lu, Ming;
Shen, Lin

Publication type:

Article